Food and Drug Regulations, C.R.C., c. 870
Section C.03.207
Cite as Food and Drug Regulations, C.R.C., c. 870, s. C.03.207 · current to June 17, 2026 · regulation last amended June 17, 2026
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) Every component shall be labelled to show
(a) adequate identification of the component and an adequate description of its function;
(b) where applicable, a quantitative list of its ingredients or a reference to the label of the kit that shows such information;
(c) the name of the distributor referred to in paragraph C.01A.003(b);
(d) the lot number;
(e) a statement of any special storage requirements with respect to temperature and light;
(f) the date after which the component is not recommended for use, the name of the month being written in full or designated by letter abbreviation; and
(g) adequate directions for use or a reference to the accompanying package insert that shows such directions.
(2) The component of a kit that is intended to contain the prepared radiopharmaceutical shall be labelled to display the drug identification number assigned for the kit, preceded by the expression “Drug Identification Number” or “Drogue : identification numérique”, or both, or the abbreviation “DIN”.
Read the Food and Drug Regulations on the Justice Laws Website ↗
Made under Food and Drugs Act, R.S.C. 1985, c. F-27.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.